ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,SUBCUTANEOUS USE,N,S
2,1,SUBCUTANEOUS USE,N,S
3,1,SUBCUTANEOUS USE,N,N
4,1,INTRAMUSCULAR,N,S
5,1,INTRAMUSCULAR,N,N
6,1,SUBCUTANEOUS USE,N,S
7,1,Routes with few reports,N,S
8,1,INTRAMUSCULAR,N,S
9,1,Routes with few reports,N,S
10,1,Routes with few reports,N,N
11,1,SUBCUTANEOUS USE,N,S
12,1,INTRAMUSCULAR,N,N
13,1,SUBCUTANEOUS USE,N,N
14,1,SUBCUTANEOUS USE,N,S
15,1,INTRAMUSCULAR,N,S
16,1,SUBCUTANEOUS USE,N,S
17,1,SUBCUTANEOUS USE,N,N
18,1,SUBCUTANEOUS USE,N,S
19,1,INTRAMUSCULAR,N,S
20,1,SUBCUTANEOUS USE,N,S
21,1,SUBCUTANEOUS USE,N,S
22,1,SUBCUTANEOUS USE,N,F
23,1,SUBCUTANEOUS USE,N,S
24,1,SUBCUTANEOUS USE,N,N
25,1,SUBCUTANEOUS USE,N,N
26,1,INTRAMUSCULAR,N,N
27,1,SUBCUTANEOUS USE,N,S
28,1,INTRAMUSCULAR,N,S
